

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 9.33623507 |
| 2 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 8.93511158 |
| 3 | mannose metabolic process (GO:0006013) | 8.88018326 |
| 4 | grooming behavior (GO:0007625) | 7.93044593 |
| 5 | regulation of female receptivity (GO:0045924) | 7.72813577 |
| 6 | aggressive behavior (GO:0002118) | 7.48337125 |
| 7 | positive regulation of amino acid transport (GO:0051957) | 7.39304654 |
| 8 | female mating behavior (GO:0060180) | 6.80423254 |
| 9 | regulation of transmission of nerve impulse (GO:0051969) | 6.63737014 |
| 10 | hyperosmotic salinity response (GO:0042538) | 6.28846754 |
| 11 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 6.13676659 |
| 12 | chemosensory behavior (GO:0007635) | 6.09447693 |
| 13 | regulation of glucocorticoid metabolic process (GO:0031943) | 6.00608843 |
| 14 | cellular response to ATP (GO:0071318) | 5.99309234 |
| 15 | metallo-sulfur cluster assembly (GO:0031163) | 5.85311019 |
| 16 | iron-sulfur cluster assembly (GO:0016226) | 5.85311019 |
| 17 | regulation of glucocorticoid secretion (GO:2000849) | 5.66204237 |
| 18 | hormone catabolic process (GO:0042447) | 5.54933470 |
| 19 | positive regulation of hair cycle (GO:0042635) | 5.27418525 |
| 20 | positive regulation of hair follicle development (GO:0051798) | 5.27418525 |
| 21 | snRNA transcription (GO:0009301) | 5.26779050 |
| 22 | protein kinase C signaling (GO:0070528) | 5.23589949 |
| 23 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.18846514 |
| 24 | peristalsis (GO:0030432) | 5.13709694 |
| 25 | positive regulation of cation channel activity (GO:2001259) | 5.07252867 |
| 26 | regulation of cell maturation (GO:1903429) | 5.07133829 |
| 27 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 5.02917981 |
| 28 | regulation of corticosteroid hormone secretion (GO:2000846) | 5.02712839 |
| 29 | positive regulation of steroid hormone secretion (GO:2000833) | 5.02576660 |
| 30 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.99053369 |
| 31 | N-glycan processing (GO:0006491) | 4.91007307 |
| 32 | maternal behavior (GO:0042711) | 4.85749794 |
| 33 | urinary tract smooth muscle contraction (GO:0014848) | 4.78294594 |
| 34 | regulation of glutamate secretion (GO:0014048) | 4.76114135 |
| 35 | positive regulation of actin filament depolymerization (GO:0030836) | 4.72186337 |
| 36 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.69837829 |
| 37 | establishment of mitochondrion localization (GO:0051654) | 4.65368616 |
| 38 | plasma membrane repair (GO:0001778) | 4.60163568 |
| 39 | positive regulation of systemic arterial blood pressure (GO:0003084) | 4.50845104 |
| 40 | GMP metabolic process (GO:0046037) | 4.49567354 |
| 41 | trivalent inorganic anion homeostasis (GO:0072506) | 4.41852567 |
| 42 | phosphate ion homeostasis (GO:0055062) | 4.41852567 |
| 43 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.35472044 |
| 44 | aldehyde catabolic process (GO:0046185) | 4.33431367 |
| 45 | NIK/NF-kappaB signaling (GO:0038061) | 4.33279065 |
| 46 | autophagic vacuole fusion (GO:0000046) | 4.27758961 |
| 47 | parental behavior (GO:0060746) | 4.27682561 |
| 48 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.27079382 |
| 49 | positive regulation of potassium ion transport (GO:0043268) | 4.13909870 |
| 50 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.10930539 |
| 51 | cellular anion homeostasis (GO:0030002) | 4.07505095 |
| 52 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 4.07299739 |
| 53 | mitochondrion transport along microtubule (GO:0047497) | 4.07003101 |
| 54 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 4.07003101 |
| 55 | peptide catabolic process (GO:0043171) | 4.06494574 |
| 56 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.06441022 |
| 57 | auditory behavior (GO:0031223) | 4.02606222 |
| 58 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.97066864 |
| 59 | determination of adult lifespan (GO:0008340) | 3.93663055 |
| 60 | mitochondrial calcium ion transport (GO:0006851) | 3.88648112 |
| 61 | sodium-independent organic anion transport (GO:0043252) | 3.88106051 |
| 62 | dendritic spine morphogenesis (GO:0060997) | 3.87796285 |
| 63 | regulation of hair follicle development (GO:0051797) | 3.87682201 |
| 64 | cAMP-mediated signaling (GO:0019933) | 3.76937435 |
| 65 | positive regulation of protein deacetylation (GO:0090312) | 3.73053542 |
| 66 | muscle filament sliding (GO:0030049) | 3.72615171 |
| 67 | actin-myosin filament sliding (GO:0033275) | 3.72615171 |
| 68 | neuronal action potential propagation (GO:0019227) | 3.68830354 |
| 69 | sarcomere organization (GO:0045214) | 3.67178516 |
| 70 | beta-amyloid metabolic process (GO:0050435) | 3.66728596 |
| 71 | positive regulation of amine transport (GO:0051954) | 3.66352111 |
| 72 | I-kappaB phosphorylation (GO:0007252) | 3.66340985 |
| 73 | carnitine transmembrane transport (GO:1902603) | 3.64919635 |
| 74 | vocalization behavior (GO:0071625) | 3.64088577 |
| 75 | peptidyl-histidine modification (GO:0018202) | 3.60623318 |
| 76 | positive regulation of organic acid transport (GO:0032892) | 3.59436299 |
| 77 | negative regulation of protein localization to cell surface (GO:2000009) | 3.57841077 |
| 78 | viral mRNA export from host cell nucleus (GO:0046784) | 3.57085443 |
| 79 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.55574071 |
| 80 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.53895205 |
| 81 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.53756666 |
| 82 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.50402010 |
| 83 | glutamine metabolic process (GO:0006541) | 3.50088908 |
| 84 | negative regulation of neurological system process (GO:0031645) | 3.45866166 |
| 85 | respiratory system process (GO:0003016) | 3.44399956 |
| 86 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.43705659 |
| 87 | regulation of cell communication by electrical coupling (GO:0010649) | 3.43229286 |
| 88 | cellular response to exogenous dsRNA (GO:0071360) | 3.42650893 |
| 89 | neuromuscular synaptic transmission (GO:0007274) | 3.42082171 |
| 90 | lung-associated mesenchyme development (GO:0060484) | 3.39379536 |
| 91 | regulation of potassium ion transmembrane transport (GO:1901379) | 3.38119950 |
| 92 | positive regulation of ion transmembrane transporter activity (GO:0032414) | 3.34659923 |
| 93 | ncRNA 3-end processing (GO:0043628) | 3.34213692 |
| 94 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.32641797 |
| 95 | skeletal muscle contraction (GO:0003009) | 3.31592322 |
| 96 | positive regulation of mitochondrial fission (GO:0090141) | 3.31102451 |
| 97 | response to testosterone (GO:0033574) | 3.29640276 |
| 98 | detection of light stimulus involved in visual perception (GO:0050908) | 3.28612143 |
| 99 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.28612143 |
| 100 | carnitine transport (GO:0015879) | 3.27648006 |
| 101 | amino-acid betaine transport (GO:0015838) | 3.27648006 |
| 102 | cell communication by electrical coupling (GO:0010644) | 3.26872458 |
| 103 | righting reflex (GO:0060013) | 3.25743527 |
| 104 | response to ATP (GO:0033198) | 3.24760363 |
| 105 | cofactor catabolic process (GO:0051187) | 3.24665920 |
| 106 | negative regulation of microtubule polymerization (GO:0031115) | 3.20711028 |
| 107 | regulation of steroid hormone secretion (GO:2000831) | 3.20153908 |
| 108 | deoxyribonucleotide catabolic process (GO:0009264) | 3.19265176 |
| 109 | response to misfolded protein (GO:0051788) | 3.19143421 |
| 110 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.18942232 |
| 111 | regulation of cation channel activity (GO:2001257) | 3.18907537 |
| 112 | regulation of amino acid transport (GO:0051955) | 3.17456550 |
| 113 | response to auditory stimulus (GO:0010996) | 3.16855554 |
| 114 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.14492586 |
| 115 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.12911010 |
| 116 | xenobiotic catabolic process (GO:0042178) | 3.11095038 |
| 117 | definitive hemopoiesis (GO:0060216) | 3.10172006 |
| 118 | protein localization to cell surface (GO:0034394) | 3.04136695 |
| 119 | cerebellum development (GO:0021549) | 3.01638542 |
| 120 | cyclic-nucleotide-mediated signaling (GO:0019935) | 3.01116786 |
| 121 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.00532567 |
| 122 | regulation of penile erection (GO:0060405) | 3.00371917 |
| 123 | phasic smooth muscle contraction (GO:0014821) | 2.99605647 |
| 124 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.99422832 |
| 125 | NADH dehydrogenase complex assembly (GO:0010257) | 2.99422832 |
| 126 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.99422832 |
| 127 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.99315002 |
| 128 | spermatid nucleus differentiation (GO:0007289) | 2.99124909 |
| 129 | hyperosmotic response (GO:0006972) | 2.97894325 |
| 130 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.97849003 |
| 131 | negative regulation of receptor activity (GO:2000272) | 2.96706625 |
| 132 | positive regulation of transporter activity (GO:0032411) | 2.96377574 |
| 133 | negative regulation of cation channel activity (GO:2001258) | 2.93969000 |
| 134 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.93068515 |
| 135 | base-excision repair, AP site formation (GO:0006285) | 2.92905210 |
| 136 | synaptic vesicle maturation (GO:0016188) | 2.92884569 |
| 137 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.92801586 |
| 138 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.92801586 |
| 139 | cell communication involved in cardiac conduction (GO:0086065) | 2.92194058 |
| 140 | regulation of skeletal muscle contraction (GO:0014819) | 2.91423346 |
| 141 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.91364457 |
| 142 | long term synaptic depression (GO:0060292) | 2.91259996 |
| 143 | regulation of phosphoprotein phosphatase activity (GO:0043666) | 2.89994239 |
| 144 | specification of organ identity (GO:0010092) | 2.89274480 |
| 145 | regulation of synapse structural plasticity (GO:0051823) | 2.88900836 |
| 146 | organelle membrane fusion (GO:0090174) | 2.87988877 |
| 147 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.87310873 |
| 148 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.87310873 |
| 149 | response to peptidoglycan (GO:0032494) | 2.84182167 |
| 150 | protein localization to synapse (GO:0035418) | 2.82822024 |
| 151 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.82094547 |
| 152 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.82094547 |
| 153 | lymphoid progenitor cell differentiation (GO:0002320) | 2.81921766 |
| 154 | deoxyribose phosphate catabolic process (GO:0046386) | 2.80770284 |
| 155 | positive regulation of protein oligomerization (GO:0032461) | 2.80423583 |
| 156 | actin-mediated cell contraction (GO:0070252) | 2.78865010 |
| 157 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.78814380 |
| 158 | response to insecticide (GO:0017085) | 2.77291443 |
| 159 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.76261231 |
| 160 | striated muscle contraction (GO:0006941) | 2.75962127 |
| 161 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.75388740 |
| 162 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.75388740 |
| 163 | regulation of sulfur metabolic process (GO:0042762) | 2.75111171 |
| 164 | positive regulation of protein depolymerization (GO:1901881) | 2.75026615 |
| 165 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.74124628 |
| 166 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.74124628 |
| 167 | creatine metabolic process (GO:0006600) | 2.71948567 |
| 168 | layer formation in cerebral cortex (GO:0021819) | 2.70707324 |
| 169 | regulation of actin filament-based movement (GO:1903115) | 2.70667229 |
| 170 | regulation of protein export from nucleus (GO:0046825) | 2.69118652 |
| 171 | cardiac muscle contraction (GO:0060048) | 2.68807830 |
| 172 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.68698501 |
| 173 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.68303326 |
| 174 | neuronal action potential (GO:0019228) | 2.67076273 |
| 175 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.66210054 |
| 176 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.65323786 |
| 177 | regulation of respiratory gaseous exchange (GO:0043576) | 2.64178982 |
| 178 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.63789389 |
| 179 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.63406885 |
| 180 | carnitine shuttle (GO:0006853) | 2.61068490 |
| 181 | negative regulation of type 2 immune response (GO:0002829) | 2.60984733 |
| 182 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.60716338 |
| 183 | regulation of relaxation of muscle (GO:1901077) | 2.58432452 |
| 184 | neuron cell-cell adhesion (GO:0007158) | 2.57735832 |
| 185 | mechanosensory behavior (GO:0007638) | 2.54417531 |
| 186 | regulation of catecholamine metabolic process (GO:0042069) | 2.54190772 |
| 187 | regulation of dopamine metabolic process (GO:0042053) | 2.54190772 |
| 188 | generation of neurons (GO:0048699) | 2.53042225 |
| 189 | negative regulation of dendrite development (GO:2000171) | 2.52720691 |
| 190 | regulation of membrane repolarization (GO:0060306) | 2.52615703 |
| 191 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.52293063 |
| 192 | regulation of lipoprotein lipase activity (GO:0051004) | 2.51859129 |
| 193 | potassium ion import (GO:0010107) | 2.50279441 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.30762678 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 7.23703708 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 6.29157281 |
| 4 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 4.66689334 |
| 5 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.76821291 |
| 6 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.78424538 |
| 7 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.78192058 |
| 8 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.70735253 |
| 9 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.70735253 |
| 10 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.66135474 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.54795862 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.51681507 |
| 13 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51447841 |
| 14 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.49101292 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.48661764 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.46578730 |
| 17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.46112097 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.43558871 |
| 19 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.39126638 |
| 20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.37093969 |
| 21 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.36018908 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.35926707 |
| 23 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.32536951 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.30357213 |
| 25 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.26349708 |
| 26 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.24577543 |
| 27 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.15568318 |
| 28 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.14983219 |
| 29 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.05624239 |
| 30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.03566690 |
| 31 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.00920954 |
| 32 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.99850914 |
| 33 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.96188879 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.96127874 |
| 35 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.94163579 |
| 36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.93382457 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.92888674 |
| 38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.91867030 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90448014 |
| 40 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.85431869 |
| 41 | P68_20966046_ChIP-Seq_HELA_Human | 1.83087483 |
| 42 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.82899133 |
| 43 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.80392878 |
| 44 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.80236263 |
| 45 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.77065372 |
| 46 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.76186103 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.75737684 |
| 48 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.73924934 |
| 49 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.72971724 |
| 50 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.71539408 |
| 51 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.70201094 |
| 52 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.69190487 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.67488172 |
| 54 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.66152098 |
| 55 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.54990449 |
| 56 | KDM2B_26808549_Chip-Seq_K562_Human | 1.54962348 |
| 57 | ERA_21632823_ChIP-Seq_H3396_Human | 1.51358907 |
| 58 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.51168516 |
| 59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.50871284 |
| 60 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.50219255 |
| 61 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.48864853 |
| 62 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.45190592 |
| 63 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.40796439 |
| 64 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.40155386 |
| 65 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.36833264 |
| 66 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.35922194 |
| 67 | FUS_26573619_Chip-Seq_HEK293_Human | 1.35665966 |
| 68 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.35614989 |
| 69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.35283472 |
| 70 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34636757 |
| 71 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.33347496 |
| 72 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.32138627 |
| 73 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.31771064 |
| 74 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.31337652 |
| 75 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.31238328 |
| 76 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.29744679 |
| 77 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27789234 |
| 78 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.27698468 |
| 79 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.27347111 |
| 80 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27310297 |
| 81 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.26439744 |
| 82 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.25563327 |
| 83 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25075784 |
| 84 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23196949 |
| 85 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.22678719 |
| 86 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.22263391 |
| 87 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.21957766 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21612373 |
| 89 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20188247 |
| 90 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20081287 |
| 91 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.19365657 |
| 92 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18725811 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18536760 |
| 94 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.16713117 |
| 95 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.15717757 |
| 96 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15204361 |
| 97 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14545250 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13579865 |
| 99 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13184750 |
| 100 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12964572 |
| 101 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11580891 |
| 102 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.11269265 |
| 103 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.10332836 |
| 104 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.10260721 |
| 105 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.10061754 |
| 106 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.08827623 |
| 107 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08700111 |
| 108 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08395220 |
| 109 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.07394323 |
| 110 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.07121261 |
| 111 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.06811299 |
| 112 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06330917 |
| 113 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05933681 |
| 114 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.05802834 |
| 115 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04718155 |
| 116 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04636995 |
| 117 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.04496909 |
| 118 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.04056626 |
| 119 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04028005 |
| 120 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.03842885 |
| 121 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.02391197 |
| 122 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.02011499 |
| 123 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01805230 |
| 124 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.01623829 |
| 125 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01147556 |
| 126 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 1.00591049 |
| 127 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00261595 |
| 128 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00061813 |
| 129 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.99113855 |
| 130 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98865921 |
| 131 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.98342156 |
| 132 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97275836 |
| 133 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.96743418 |
| 134 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96338755 |
| 135 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.96086547 |
| 136 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95115517 |
| 137 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95115517 |
| 138 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94784394 |
| 139 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94506082 |
| 140 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.93871344 |
| 141 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92784454 |
| 142 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92672989 |
| 143 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92425401 |
| 144 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.92300323 |
| 145 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92249171 |
| 146 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.90107654 |
| 147 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.89689434 |
| 148 | * LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.89469953 |
| 149 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.89346933 |
| 150 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.89245813 |
| 151 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.88935732 |
| 152 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88606310 |
| 153 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.88443045 |
| 154 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.88329720 |
| 155 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88029351 |
| 156 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87444424 |
| 157 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.86516748 |
| 158 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.86263200 |
| 159 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.85509103 |
| 160 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85468538 |
| 161 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.84997509 |
| 162 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84496802 |
| 163 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82466579 |
| 164 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.82126639 |
| 165 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.81928235 |
| 166 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.81760358 |
| 167 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.81508794 |
| 168 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.80682664 |
| 169 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79048974 |
| 170 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78556931 |
| 171 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.78400173 |
| 172 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.77423338 |
| 173 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.77423338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002163_abnormal_gland_morphology | 5.77390729 |
| 2 | MP0004858_abnormal_nervous_system | 5.64415402 |
| 3 | MP0005645_abnormal_hypothalamus_physiol | 5.11926139 |
| 4 | MP0009278_abnormal_bone_marrow | 4.57633263 |
| 5 | MP0002653_abnormal_ependyma_morphology | 4.52949070 |
| 6 | MP0002396_abnormal_hematopoietic_system | 4.42470174 |
| 7 | MP0005379_endocrine/exocrine_gland_phen | 4.06241252 |
| 8 | MP0000751_myopathy | 3.75817225 |
| 9 | MP0000678_abnormal_parathyroid_gland | 3.69318217 |
| 10 | MP0001986_abnormal_taste_sensitivity | 3.65679269 |
| 11 | MP0004145_abnormal_muscle_electrophysio | 3.55928538 |
| 12 | MP0002735_abnormal_chemical_nociception | 3.52160625 |
| 13 | MP0005646_abnormal_pituitary_gland | 3.34424704 |
| 14 | MP0001968_abnormal_touch/_nociception | 3.31834501 |
| 15 | MP0008004_abnormal_stomach_pH | 3.16341455 |
| 16 | MP0004859_abnormal_synaptic_plasticity | 2.72997207 |
| 17 | MP0004270_analgesia | 2.70143000 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 2.61764716 |
| 19 | MP0005451_abnormal_body_composition | 2.54788358 |
| 20 | MP0006276_abnormal_autonomic_nervous | 2.53116682 |
| 21 | MP0000749_muscle_degeneration | 2.51533733 |
| 22 | MP0003656_abnormal_erythrocyte_physiolo | 2.40785665 |
| 23 | MP0000604_amyloidosis | 2.34595046 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.33963380 |
| 25 | MP0003646_muscle_fatigue | 2.27039324 |
| 26 | MP0008775_abnormal_heart_ventricle | 2.25653518 |
| 27 | MP0003880_abnormal_central_pattern | 2.24673120 |
| 28 | MP0000465_gastrointestinal_hemorrhage | 2.17966930 |
| 29 | MP0005423_abnormal_somatic_nervous | 2.16750476 |
| 30 | MP0002734_abnormal_mechanical_nocicepti | 2.16033900 |
| 31 | MP0008789_abnormal_olfactory_epithelium | 2.09671234 |
| 32 | MP0005499_abnormal_olfactory_system | 2.05661563 |
| 33 | MP0005394_taste/olfaction_phenotype | 2.05661563 |
| 34 | MP0001545_abnormal_hematopoietic_system | 2.04981701 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 2.04981701 |
| 36 | MP0002106_abnormal_muscle_physiology | 2.03431352 |
| 37 | MP0000747_muscle_weakness | 2.00102817 |
| 38 | MP0003635_abnormal_synaptic_transmissio | 1.92770310 |
| 39 | MP0001984_abnormal_olfaction | 1.89293739 |
| 40 | MP0002822_catalepsy | 1.84741999 |
| 41 | MP0004036_abnormal_muscle_relaxation | 1.81850724 |
| 42 | MP0004087_abnormal_muscle_fiber | 1.80785221 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 1.78722519 |
| 44 | MP0004484_altered_response_of | 1.77133463 |
| 45 | MP0004084_abnormal_cardiac_muscle | 1.75488453 |
| 46 | MP0004130_abnormal_muscle_cell | 1.75202107 |
| 47 | MP0009745_abnormal_behavioral_response | 1.71303875 |
| 48 | MP0000759_abnormal_skeletal_muscle | 1.69323217 |
| 49 | MP0005620_abnormal_muscle_contractility | 1.68503486 |
| 50 | MP0005369_muscle_phenotype | 1.60405738 |
| 51 | MP0000750_abnormal_muscle_regeneration | 1.59348205 |
| 52 | MP0002733_abnormal_thermal_nociception | 1.58205184 |
| 53 | MP0004215_abnormal_myocardial_fiber | 1.55399455 |
| 54 | MP0002269_muscular_atrophy | 1.52379321 |
| 55 | MP0005330_cardiomyopathy | 1.49725736 |
| 56 | MP0002972_abnormal_cardiac_muscle | 1.49583397 |
| 57 | MP0001664_abnormal_digestion | 1.48408581 |
| 58 | MP0005670_abnormal_white_adipose | 1.41716857 |
| 59 | MP0002063_abnormal_learning/memory/cond | 1.40254821 |
| 60 | MP0001905_abnormal_dopamine_level | 1.38989568 |
| 61 | MP0002272_abnormal_nervous_system | 1.36997548 |
| 62 | MP0001529_abnormal_vocalization | 1.28643046 |
| 63 | MP0001970_abnormal_pain_threshold | 1.27907451 |
| 64 | MP0002184_abnormal_innervation | 1.27729919 |
| 65 | * MP0002572_abnormal_emotion/affect_behav | 1.25349631 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 1.24960313 |
| 67 | MP0001440_abnormal_grooming_behavior | 1.23261167 |
| 68 | MP0002971_abnormal_brown_adipose | 1.18634378 |
| 69 | MP0006072_abnormal_retinal_apoptosis | 1.17242599 |
| 70 | MP0000003_abnormal_adipose_tissue | 1.16856707 |
| 71 | MP0002067_abnormal_sensory_capabilities | 1.16360030 |
| 72 | MP0008872_abnormal_physiological_respon | 1.12748435 |
| 73 | MP0008995_early_reproductive_senescence | 1.12740896 |
| 74 | MP0005165_increased_susceptibility_to | 1.11737773 |
| 75 | MP0003632_abnormal_nervous_system | 1.09046738 |
| 76 | MP0005386_behavior/neurological_phenoty | 1.08569126 |
| 77 | MP0004924_abnormal_behavior | 1.08569126 |
| 78 | MP0004085_abnormal_heartbeat | 1.08445833 |
| 79 | MP0002064_seizures | 1.08440057 |
| 80 | MP0003137_abnormal_impulse_conducting | 1.08058235 |
| 81 | MP0002234_abnormal_pharynx_morphology | 1.06248338 |
| 82 | MP0005084_abnormal_gallbladder_morpholo | 1.06173824 |
| 83 | MP0003329_amyloid_beta_deposits | 1.03662468 |
| 84 | MP0009333_abnormal_splenocyte_physiolog | 1.01427735 |
| 85 | MP0006292_abnormal_olfactory_placode | 0.99650500 |
| 86 | MP0001188_hyperpigmentation | 0.98994804 |
| 87 | MP0000427_abnormal_hair_cycle | 0.98862138 |
| 88 | * MP0001486_abnormal_startle_reflex | 0.98227528 |
| 89 | MP0003718_maternal_effect | 0.96171608 |
| 90 | MP0002332_abnormal_exercise_endurance | 0.96081185 |
| 91 | MP0002736_abnormal_nociception_after | 0.95975378 |
| 92 | MP0000639_abnormal_adrenal_gland | 0.95972020 |
| 93 | MP0002127_abnormal_cardiovascular_syste | 0.95047868 |
| 94 | MP0002132_abnormal_respiratory_system | 0.91815190 |
| 95 | MP0002102_abnormal_ear_morphology | 0.91502418 |
| 96 | MP0000013_abnormal_adipose_tissue | 0.89759334 |
| 97 | MP0004811_abnormal_neuron_physiology | 0.89635736 |
| 98 | MP0008569_lethality_at_weaning | 0.88860244 |
| 99 | MP0005636_abnormal_mineral_homeostasis | 0.87746230 |
| 100 | MP0005334_abnormal_fat_pad | 0.87317574 |
| 101 | MP0002069_abnormal_eating/drinking_beha | 0.86720790 |
| 102 | MP0004142_abnormal_muscle_tone | 0.84897515 |
| 103 | MP0002160_abnormal_reproductive_system | 0.82833435 |
| 104 | MP0002405_respiratory_system_inflammati | 0.82132583 |
| 105 | MP0004233_abnormal_muscle_weight | 0.81511587 |
| 106 | MP0001727_abnormal_embryo_implantation | 0.79050380 |
| 107 | MP0003122_maternal_imprinting | 0.78586924 |
| 108 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78504524 |
| 109 | MP0004883_abnormal_blood_vessel | 0.77706182 |
| 110 | MP0005385_cardiovascular_system_phenoty | 0.77331960 |
| 111 | MP0001544_abnormal_cardiovascular_syste | 0.77331960 |
| 112 | MP0003183_abnormal_peptide_metabolism | 0.76845297 |
| 113 | MP0003948_abnormal_gas_homeostasis | 0.75120821 |
| 114 | MP0001765_abnormal_ion_homeostasis | 0.74569621 |
| 115 | MP0001756_abnormal_urination | 0.72994744 |
| 116 | MP0004885_abnormal_endolymph | 0.72734943 |
| 117 | MP0001177_atelectasis | 0.72141901 |
| 118 | MP0001790_abnormal_immune_system | 0.71831761 |
| 119 | MP0005387_immune_system_phenotype | 0.71831761 |
| 120 | MP0004272_abnormal_basement_membrane | 0.71402084 |
| 121 | MP0002066_abnormal_motor_capabilities/c | 0.69998011 |
| 122 | MP0009643_abnormal_urine_homeostasis | 0.69541572 |
| 123 | MP0010630_abnormal_cardiac_muscle | 0.67402220 |
| 124 | * MP0002882_abnormal_neuron_morphology | 0.65174321 |
| 125 | MP0003638_abnormal_response/metabolism_ | 0.64989505 |
| 126 | MP0003385_abnormal_body_wall | 0.64716571 |
| 127 | MP0005535_abnormal_body_temperature | 0.64559896 |
| 128 | MP0001958_emphysema | 0.63141461 |
| 129 | MP0005647_abnormal_sex_gland | 0.63020199 |
| 130 | MP0005332_abnormal_amino_acid | 0.61507265 |
| 131 | MP0003890_abnormal_embryonic-extraembry | 0.61330121 |
| 132 | MP0009840_abnormal_foam_cell | 0.60997067 |
| 133 | MP0000681_abnormal_thyroid_gland | 0.60782191 |
| 134 | MP0002638_abnormal_pupillary_reflex | 0.60096249 |
| 135 | MP0005253_abnormal_eye_physiology | 0.60093114 |
| 136 | MP0000955_abnormal_spinal_cord | 0.59983783 |
| 137 | MP0006138_congestive_heart_failure | 0.59278604 |
| 138 | MP0003123_paternal_imprinting | 0.57758010 |
| 139 | MP0009046_muscle_twitch | 0.57596842 |
| 140 | MP0000778_abnormal_nervous_system | 0.57197858 |
| 141 | MP0003315_abnormal_perineum_morphology | 0.56325544 |
| 142 | MP0003631_nervous_system_phenotype | 0.55514725 |
| 143 | MP0006036_abnormal_mitochondrial_physio | 0.54790419 |
| 144 | MP0009115_abnormal_fat_cell | 0.54777408 |
| 145 | MP0002751_abnormal_autonomic_nervous | 0.54288597 |
| 146 | MP0002098_abnormal_vibrissa_morphology | 0.53968684 |
| 147 | MP0005623_abnormal_meninges_morphology | 0.53138374 |
| 148 | MP0000371_diluted_coat_color | 0.52698102 |
| 149 | MP0008873_increased_physiological_sensi | 0.52140106 |
| 150 | MP0000733_abnormal_muscle_development | 0.51678753 |
| 151 | MP0000538_abnormal_urinary_bladder | 0.51183204 |
| 152 | MP0008875_abnormal_xenobiotic_pharmacok | 0.50495146 |
| 153 | MP0005266_abnormal_metabolism | 0.50455195 |
| 154 | MP0002229_neurodegeneration | 0.50339954 |
| 155 | MP0002909_abnormal_adrenal_gland | 0.49750032 |
| 156 | MP0003186_abnormal_redox_activity | 0.48940414 |
| 157 | MP0005167_abnormal_blood-brain_barrier | 0.48858068 |
| 158 | MP0002557_abnormal_social/conspecific_i | 0.48619858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Generalized aminoaciduria (HP:0002909) | 7.41650165 |
| 2 | Male infertility (HP:0003251) | 6.54322475 |
| 3 | Renal Fanconi syndrome (HP:0001994) | 6.15018216 |
| 4 | Hypophosphatemic rickets (HP:0004912) | 5.98955735 |
| 5 | Hyporeflexia of lower limbs (HP:0002600) | 5.89876210 |
| 6 | Distal lower limb muscle weakness (HP:0009053) | 5.56402416 |
| 7 | Exercise-induced myalgia (HP:0003738) | 4.90299504 |
| 8 | Abnormality of the costochondral junction (HP:0000919) | 4.87672067 |
| 9 | Muscle fiber splitting (HP:0003555) | 4.76369099 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 4.57102431 |
| 11 | Recurrent corneal erosions (HP:0000495) | 4.38779443 |
| 12 | Muscle fiber inclusion bodies (HP:0100299) | 4.32780768 |
| 13 | Fetal akinesia sequence (HP:0001989) | 4.32016435 |
| 14 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.31297983 |
| 15 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.22611638 |
| 16 | Areflexia of lower limbs (HP:0002522) | 4.18682101 |
| 17 | Sudden death (HP:0001699) | 4.10702424 |
| 18 | Myotonia (HP:0002486) | 4.10051167 |
| 19 | Calf muscle hypertrophy (HP:0008981) | 4.09228052 |
| 20 | Ulnar claw (HP:0001178) | 4.09212422 |
| 21 | Delayed puberty (HP:0000823) | 4.08121910 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.04794367 |
| 23 | Abnormal drinking behavior (HP:0030082) | 3.96871742 |
| 24 | Polydipsia (HP:0001959) | 3.96871742 |
| 25 | Tetany (HP:0001281) | 3.94613799 |
| 26 | Difficulty running (HP:0009046) | 3.93736241 |
| 27 | Nemaline bodies (HP:0003798) | 3.83224751 |
| 28 | EMG: myopathic abnormalities (HP:0003458) | 3.64796683 |
| 29 | Hypoglycemic seizures (HP:0002173) | 3.55079352 |
| 30 | Distal lower limb amyotrophy (HP:0008944) | 3.45942987 |
| 31 | Abnormality of renal resorption (HP:0011038) | 3.41591612 |
| 32 | Hyperphosphatemia (HP:0002905) | 3.38940657 |
| 33 | Myokymia (HP:0002411) | 3.38928390 |
| 34 | Muscle stiffness (HP:0003552) | 3.37563649 |
| 35 | Calcaneovalgus deformity (HP:0001848) | 3.33230778 |
| 36 | Foot dorsiflexor weakness (HP:0009027) | 3.24985619 |
| 37 | Abnormality of the calf musculature (HP:0001430) | 3.24386879 |
| 38 | EMG: neuropathic changes (HP:0003445) | 3.16695194 |
| 39 | Lower limb amyotrophy (HP:0007210) | 3.15881583 |
| 40 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.10575283 |
| 41 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.10575283 |
| 42 | Increased variability in muscle fiber diameter (HP:0003557) | 3.08230424 |
| 43 | Congenital stationary night blindness (HP:0007642) | 3.07885848 |
| 44 | Deformed tarsal bones (HP:0008119) | 3.03557646 |
| 45 | Myoglobinuria (HP:0002913) | 3.02908882 |
| 46 | Nephrogenic diabetes insipidus (HP:0009806) | 3.00395455 |
| 47 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.99414155 |
| 48 | Abnormality of the foot musculature (HP:0001436) | 2.98438347 |
| 49 | Distal arthrogryposis (HP:0005684) | 2.97777200 |
| 50 | Gait imbalance (HP:0002141) | 2.93730224 |
| 51 | Type 1 muscle fiber predominance (HP:0003803) | 2.92263432 |
| 52 | Polyuria (HP:0000103) | 2.87554325 |
| 53 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.85862992 |
| 54 | Increased connective tissue (HP:0009025) | 2.85061700 |
| 55 | Ankle clonus (HP:0011448) | 2.80425340 |
| 56 | Axonal loss (HP:0003447) | 2.79577870 |
| 57 | Exocrine pancreatic insufficiency (HP:0001738) | 2.78840140 |
| 58 | Abnormality of urine glucose concentration (HP:0011016) | 2.77191437 |
| 59 | Glycosuria (HP:0003076) | 2.77191437 |
| 60 | Absent speech (HP:0001344) | 2.76880906 |
| 61 | Hyponatremia (HP:0002902) | 2.76664224 |
| 62 | Steppage gait (HP:0003376) | 2.75877079 |
| 63 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.75325442 |
| 64 | Acute lymphatic leukemia (HP:0006721) | 2.70507374 |
| 65 | Congenital primary aphakia (HP:0007707) | 2.70154270 |
| 66 | Difficulty climbing stairs (HP:0003551) | 2.68037712 |
| 67 | Increased intramyocellular lipid droplets (HP:0012240) | 2.67494824 |
| 68 | Type I diabetes mellitus (HP:0100651) | 2.64173595 |
| 69 | Increased muscle lipid content (HP:0009058) | 2.62289145 |
| 70 | Ventricular fibrillation (HP:0001663) | 2.59535123 |
| 71 | Medial flaring of the eyebrow (HP:0010747) | 2.57027319 |
| 72 | Urinary urgency (HP:0000012) | 2.53111472 |
| 73 | Ventricular tachycardia (HP:0004756) | 2.51018512 |
| 74 | Muscle fiber atrophy (HP:0100295) | 2.49577529 |
| 75 | Aplasia of the musculature (HP:0100854) | 2.46853664 |
| 76 | Atrial fibrillation (HP:0005110) | 2.45159014 |
| 77 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.43204809 |
| 78 | Ulnar deviation of the wrist (HP:0003049) | 2.42201358 |
| 79 | Hepatocellular necrosis (HP:0001404) | 2.41605827 |
| 80 | Mitochondrial inheritance (HP:0001427) | 2.41228469 |
| 81 | Progressive neurologic deterioration (HP:0002344) | 2.41177299 |
| 82 | Primary atrial arrhythmia (HP:0001692) | 2.40090103 |
| 83 | Popliteal pterygium (HP:0009756) | 2.40021022 |
| 84 | Dysautonomia (HP:0002459) | 2.39918448 |
| 85 | Abnormal urine output (HP:0012590) | 2.38891348 |
| 86 | Hypoparathyroidism (HP:0000829) | 2.38657008 |
| 87 | Increased IgM level (HP:0003496) | 2.37356032 |
| 88 | Neck muscle weakness (HP:0000467) | 2.33851055 |
| 89 | Akinesia (HP:0002304) | 2.33425789 |
| 90 | Pheochromocytoma (HP:0002666) | 2.31568018 |
| 91 | Myopathic facies (HP:0002058) | 2.31549113 |
| 92 | Rimmed vacuoles (HP:0003805) | 2.29191114 |
| 93 | Hyperacusis (HP:0010780) | 2.29189662 |
| 94 | Termporal pattern (HP:0011008) | 2.25670246 |
| 95 | Insidious onset (HP:0003587) | 2.25670246 |
| 96 | Decreased testicular size (HP:0008734) | 2.25381168 |
| 97 | Metaphyseal dysplasia (HP:0100255) | 2.25362192 |
| 98 | Malignant hyperthermia (HP:0002047) | 2.25341659 |
| 99 | Supraventricular tachycardia (HP:0004755) | 2.24708028 |
| 100 | Abnormality of the corticospinal tract (HP:0002492) | 2.22998837 |
| 101 | Supraventricular arrhythmia (HP:0005115) | 2.21821504 |
| 102 | Neuroendocrine neoplasm (HP:0100634) | 2.21766724 |
| 103 | Round ear (HP:0100830) | 2.20621226 |
| 104 | Right ventricular cardiomyopathy (HP:0011663) | 2.19376543 |
| 105 | Atrioventricular block (HP:0001678) | 2.15894336 |
| 106 | Bundle branch block (HP:0011710) | 2.15737705 |
| 107 | Portal hypertension (HP:0001409) | 2.15708607 |
| 108 | Abnormality of placental membranes (HP:0011409) | 2.14801401 |
| 109 | Amniotic constriction ring (HP:0009775) | 2.14801401 |
| 110 | Rickets (HP:0002748) | 2.14198608 |
| 111 | Hepatic necrosis (HP:0002605) | 2.11951548 |
| 112 | Neonatal respiratory distress (HP:0002643) | 2.09033758 |
| 113 | Type 2 muscle fiber atrophy (HP:0003554) | 2.07811658 |
| 114 | Decreased muscle mass (HP:0003199) | 2.06985778 |
| 115 | Hypokalemia (HP:0002900) | 2.04734266 |
| 116 | Long clavicles (HP:0000890) | 2.04184410 |
| 117 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.04037060 |
| 118 | Abnormality of alanine metabolism (HP:0010916) | 2.04037060 |
| 119 | Hyperalaninemia (HP:0003348) | 2.04037060 |
| 120 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.04012959 |
| 121 | Subaortic stenosis (HP:0001682) | 2.04012959 |
| 122 | Decreased motor nerve conduction velocity (HP:0003431) | 2.02445009 |
| 123 | Palpitations (HP:0001962) | 2.01871373 |
| 124 | Ventricular arrhythmia (HP:0004308) | 2.01819303 |
| 125 | Abnormality of the hepatic vasculature (HP:0006707) | 2.00566565 |
| 126 | Symptomatic seizures (HP:0011145) | 2.00450709 |
| 127 | Gastrointestinal stroma tumor (HP:0100723) | 2.00330778 |
| 128 | Abnormality of sodium homeostasis (HP:0010931) | 1.99136147 |
| 129 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.98928602 |
| 130 | Abnormality of renal excretion (HP:0011036) | 1.97023320 |
| 131 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.96949913 |
| 132 | Action tremor (HP:0002345) | 1.96897860 |
| 133 | Polyphagia (HP:0002591) | 1.96044880 |
| 134 | Hypertensive crisis (HP:0100735) | 1.94718392 |
| 135 | Unilateral renal agenesis (HP:0000122) | 1.93944270 |
| 136 | External ophthalmoplegia (HP:0000544) | 1.93222112 |
| 137 | Hypoplastic heart (HP:0001961) | 1.93170720 |
| 138 | Distal sensory impairment (HP:0002936) | 1.92826634 |
| 139 | Elfin facies (HP:0004428) | 1.92539131 |
| 140 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.92146279 |
| 141 | Lipoatrophy (HP:0100578) | 1.91903320 |
| 142 | Rhabdomyolysis (HP:0003201) | 1.91807146 |
| 143 | Multiple enchondromatosis (HP:0005701) | 1.90678003 |
| 144 | Achilles tendon contracture (HP:0001771) | 1.90197479 |
| 145 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.89899583 |
| 146 | Febrile seizures (HP:0002373) | 1.89109902 |
| 147 | Onion bulb formation (HP:0003383) | 1.88574227 |
| 148 | Acute necrotizing encephalopathy (HP:0006965) | 1.88324220 |
| 149 | Poor suck (HP:0002033) | 1.86615658 |
| 150 | Increased CSF lactate (HP:0002490) | 1.85852225 |
| 151 | Heart block (HP:0012722) | 1.82836930 |
| 152 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.82426721 |
| 153 | Shoulder girdle muscle weakness (HP:0003547) | 1.81881468 |
| 154 | Nasal speech (HP:0001611) | 1.81727230 |
| 155 | Abnormality of the calcaneus (HP:0008364) | 1.81487106 |
| 156 | Abnormality of the Achilles tendon (HP:0005109) | 1.80949212 |
| 157 | Acute encephalopathy (HP:0006846) | 1.80939908 |
| 158 | Focal motor seizures (HP:0011153) | 1.80658751 |
| 159 | Optic disc pallor (HP:0000543) | 1.79741680 |
| 160 | Gliosis (HP:0002171) | 1.78908572 |
| 161 | Vaginal atresia (HP:0000148) | 1.78446707 |
| 162 | Wrist flexion contracture (HP:0001239) | 1.77496611 |
| 163 | Dysphonia (HP:0001618) | 1.76424935 |
| 164 | Rapidly progressive (HP:0003678) | 1.75948930 |
| 165 | Syncope (HP:0001279) | 1.75590642 |
| 166 | Orthostatic hypotension (HP:0001278) | 1.75211595 |
| 167 | Limb dystonia (HP:0002451) | 1.74564852 |
| 168 | Proximal amyotrophy (HP:0007126) | 1.74185667 |
| 169 | Abnormal atrioventricular conduction (HP:0005150) | 1.73997940 |
| 170 | Gout (HP:0001997) | 1.73726634 |
| 171 | Lissencephaly (HP:0001339) | 1.73515675 |
| 172 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.73335643 |
| 173 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.73080695 |
| 174 | Generalized tonic-clonic seizures (HP:0002069) | 1.72853314 |
| 175 | Failure to thrive in infancy (HP:0001531) | 1.72677343 |
| 176 | Polygenic inheritance (HP:0010982) | 1.71648083 |
| 177 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.70597681 |
| 178 | Delusions (HP:0000746) | 1.70411283 |
| 179 | Overriding aorta (HP:0002623) | 1.70328133 |
| 180 | Agammaglobulinemia (HP:0004432) | 1.70129949 |
| 181 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.68929465 |
| 182 | Lactic acidosis (HP:0003128) | 1.67926925 |
| 183 | Truncal obesity (HP:0001956) | 1.67609881 |
| 184 | Renovascular hypertension (HP:0100817) | 1.66341702 |
| 185 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.65375834 |
| 186 | Genital tract atresia (HP:0001827) | 1.64311395 |
| 187 | Macroglossia (HP:0000158) | 1.62722414 |
| 188 | Progressive macrocephaly (HP:0004481) | 1.62685847 |
| 189 | Abnormal EKG (HP:0003115) | 1.62606545 |
| 190 | Alacrima (HP:0000522) | 1.61735212 |
| 191 | Infertility (HP:0000789) | 1.61232733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 7.74181514 |
| 2 | FLT3 | 5.58518022 |
| 3 | MAP3K11 | 4.44800448 |
| 4 | PRKG2 | 4.21862570 |
| 5 | MAP4K1 | 3.07713761 |
| 6 | MAPKAPK3 | 3.07211546 |
| 7 | PHKG1 | 2.80926402 |
| 8 | PHKG2 | 2.80926402 |
| 9 | KIT | 2.78716257 |
| 10 | PRKD2 | 2.71750985 |
| 11 | NEK1 | 2.66164200 |
| 12 | NLK | 2.59292596 |
| 13 | TTN | 2.52340021 |
| 14 | TAOK2 | 2.43790493 |
| 15 | PRPF4B | 2.35457242 |
| 16 | BLK | 2.32570672 |
| 17 | MARK1 | 2.30214873 |
| 18 | EPHB1 | 2.29594800 |
| 19 | PNCK | 2.18195001 |
| 20 | TRIB3 | 2.08984689 |
| 21 | NTRK3 | 2.08308193 |
| 22 | OBSCN | 2.00337277 |
| 23 | MAP4K2 | 1.99623290 |
| 24 | MINK1 | 1.95633259 |
| 25 | CAMK1G | 1.88726405 |
| 26 | CSF1R | 1.77801709 |
| 27 | UHMK1 | 1.75437437 |
| 28 | PAK6 | 1.70740020 |
| 29 | IKBKE | 1.57779815 |
| 30 | CAMKK2 | 1.46407117 |
| 31 | PIK3CA | 1.43609931 |
| 32 | PKN1 | 1.43424874 |
| 33 | LMTK2 | 1.41948690 |
| 34 | NME1 | 1.41711931 |
| 35 | CDC42BPA | 1.40636865 |
| 36 | MUSK | 1.34051679 |
| 37 | TAOK1 | 1.33135411 |
| 38 | TRIM28 | 1.32718845 |
| 39 | TESK1 | 1.31367515 |
| 40 | ADRBK2 | 1.28444781 |
| 41 | NTRK1 | 1.22601139 |
| 42 | PAK3 | 1.19652021 |
| 43 | LATS2 | 1.18601643 |
| 44 | NTRK2 | 1.15009036 |
| 45 | GRK5 | 1.14329935 |
| 46 | ZAK | 1.09005130 |
| 47 | MAPK12 | 1.07961546 |
| 48 | CAMKK1 | 1.07324358 |
| 49 | RPS6KB2 | 1.05608637 |
| 50 | LIMK1 | 1.05547552 |
| 51 | BCR | 1.05264851 |
| 52 | MAP2K4 | 1.03628908 |
| 53 | ALK | 0.98682896 |
| 54 | MAP3K9 | 0.98386943 |
| 55 | MARK2 | 0.97393964 |
| 56 | STK38 | 0.96921303 |
| 57 | CDK19 | 0.96332655 |
| 58 | ZAP70 | 0.95192781 |
| 59 | TAOK3 | 0.93161835 |
| 60 | PINK1 | 0.89455340 |
| 61 | PIM2 | 0.81098870 |
| 62 | MAPK13 | 0.80181109 |
| 63 | ROCK2 | 0.79329368 |
| 64 | INSRR | 0.78748381 |
| 65 | SIK2 | 0.78344432 |
| 66 | FES | 0.78195855 |
| 67 | CAMK1 | 0.77021833 |
| 68 | PDK3 | 0.76263784 |
| 69 | PDK4 | 0.76263784 |
| 70 | SGK223 | 0.74806203 |
| 71 | SGK494 | 0.74806203 |
| 72 | MAPK4 | 0.74607617 |
| 73 | MAP2K7 | 0.74065670 |
| 74 | MAP3K12 | 0.72438850 |
| 75 | TIE1 | 0.70997720 |
| 76 | DYRK1A | 0.69711378 |
| 77 | CAMK1D | 0.69595021 |
| 78 | ABL2 | 0.69129373 |
| 79 | KSR2 | 0.68925412 |
| 80 | DYRK1B | 0.67915940 |
| 81 | CAMK2A | 0.67798612 |
| 82 | SCYL2 | 0.66408620 |
| 83 | CCNB1 | 0.65871073 |
| 84 | PRKCE | 0.65476782 |
| 85 | CDK5 | 0.65018276 |
| 86 | FER | 0.64730714 |
| 87 | ERBB3 | 0.61657976 |
| 88 | GRK1 | 0.61405302 |
| 89 | PTK2 | 0.61125848 |
| 90 | NEK6 | 0.60241282 |
| 91 | SIK3 | 0.59592470 |
| 92 | PRKD1 | 0.58309095 |
| 93 | CAMK2G | 0.58236746 |
| 94 | VRK2 | 0.54682280 |
| 95 | BUB1 | 0.54491859 |
| 96 | CDK14 | 0.53772668 |
| 97 | CAMK2D | 0.53734147 |
| 98 | DYRK2 | 0.53567423 |
| 99 | STK11 | 0.53040785 |
| 100 | DAPK1 | 0.51908537 |
| 101 | MAP2K6 | 0.51721746 |
| 102 | PRKG1 | 0.50573305 |
| 103 | PDGFRA | 0.50477483 |
| 104 | PTK6 | 0.49966042 |
| 105 | MAP3K1 | 0.49129860 |
| 106 | PKN2 | 0.48652724 |
| 107 | CSNK1G3 | 0.48507405 |
| 108 | MAP3K4 | 0.47741145 |
| 109 | PRKCG | 0.46218389 |
| 110 | SIK1 | 0.44535019 |
| 111 | MYLK | 0.44333046 |
| 112 | PIM1 | 0.44250198 |
| 113 | PIK3CG | 0.42179504 |
| 114 | PLK2 | 0.40427526 |
| 115 | MAP2K1 | 0.40087155 |
| 116 | PRKAA2 | 0.40085649 |
| 117 | PRKCH | 0.39965855 |
| 118 | MAP2K2 | 0.39963088 |
| 119 | TESK2 | 0.39658665 |
| 120 | MAP3K13 | 0.38218008 |
| 121 | OXSR1 | 0.37951913 |
| 122 | KDR | 0.37714971 |
| 123 | TBK1 | 0.37339730 |
| 124 | CAMK4 | 0.37274582 |
| 125 | MOS | 0.36700667 |
| 126 | CDK11A | 0.36429248 |
| 127 | RPS6KA5 | 0.35994677 |
| 128 | TNK2 | 0.35505374 |
| 129 | MATK | 0.35157325 |
| 130 | ROCK1 | 0.34697741 |
| 131 | PRKAA1 | 0.34122043 |
| 132 | CSNK1G2 | 0.33194212 |
| 133 | PRKACA | 0.32279038 |
| 134 | DAPK3 | 0.32096600 |
| 135 | MAP3K7 | 0.31981897 |
| 136 | DMPK | 0.31741404 |
| 137 | CSNK1E | 0.30482011 |
| 138 | EPHA4 | 0.29383562 |
| 139 | EPHA3 | 0.28920226 |
| 140 | MAP2K3 | 0.28193643 |
| 141 | JAK2 | 0.26899793 |
| 142 | PRKACG | 0.26626599 |
| 143 | IKBKB | 0.26260668 |
| 144 | CDK7 | 0.25864946 |
| 145 | RPS6KC1 | 0.25732686 |
| 146 | RPS6KL1 | 0.25732686 |
| 147 | PAK2 | 0.24744671 |
| 148 | RPS6KA6 | 0.23655731 |
| 149 | RPS6KB1 | 0.22805004 |
| 150 | CSNK1A1 | 0.21370948 |
| 151 | CSNK1A1L | 0.20912158 |
| 152 | FYN | 0.20382458 |
| 153 | HIPK2 | 0.19760876 |
| 154 | MAPK3 | 0.18543667 |
| 155 | PRKCQ | 0.18448054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.45572692 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.83215540 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.80408218 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.63456416 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.54020681 |
| 6 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.52803872 |
| 7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.46457116 |
| 8 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.44680928 |
| 9 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.43910153 |
| 10 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.41516167 |
| 11 | Phototransduction_Homo sapiens_hsa04744 | 2.40444483 |
| 12 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.34419851 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.30041458 |
| 14 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.29565052 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.21818746 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.11035451 |
| 17 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.08492549 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.97750216 |
| 19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.91123863 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.88721027 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.74984424 |
| 22 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.66301263 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.62639623 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.56874341 |
| 25 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.55881875 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.46696416 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.46296115 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.43968620 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.42077904 |
| 30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.39813923 |
| 31 | GABAergic synapse_Homo sapiens_hsa04727 | 1.39653879 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.38013211 |
| 33 | Taste transduction_Homo sapiens_hsa04742 | 1.36913206 |
| 34 | Galactose metabolism_Homo sapiens_hsa00052 | 1.36855226 |
| 35 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.30103074 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.25175750 |
| 37 | Nicotine addiction_Homo sapiens_hsa05033 | 1.23855506 |
| 38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.23837636 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.20646875 |
| 40 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.19806480 |
| 41 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.19221643 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18819680 |
| 43 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.17565384 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.16831802 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.11454850 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.11401509 |
| 47 | Gap junction_Homo sapiens_hsa04540 | 1.10808049 |
| 48 | Circadian entrainment_Homo sapiens_hsa04713 | 1.08784938 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05678296 |
| 50 | Long-term potentiation_Homo sapiens_hsa04720 | 1.05670916 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04094761 |
| 52 | Renin secretion_Homo sapiens_hsa04924 | 1.03831956 |
| 53 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.02992571 |
| 54 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.00428585 |
| 55 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.99742722 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.98871470 |
| 57 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.98025344 |
| 58 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.97691981 |
| 59 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.96810068 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95959675 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 0.95893064 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.94830338 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94320867 |
| 64 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.89322402 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.88969042 |
| 66 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.88422393 |
| 67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.87508159 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.87437079 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86670456 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.86420349 |
| 71 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.86142882 |
| 72 | Morphine addiction_Homo sapiens_hsa05032 | 0.84604808 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84485530 |
| 74 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.84296541 |
| 75 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.83374463 |
| 76 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.82188465 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81543428 |
| 78 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80466007 |
| 79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.80313120 |
| 80 | Melanogenesis_Homo sapiens_hsa04916 | 0.79590005 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.79175955 |
| 82 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.78645175 |
| 83 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.78261862 |
| 84 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75345446 |
| 85 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75272202 |
| 86 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75266236 |
| 87 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74927232 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.74185549 |
| 89 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.73965191 |
| 90 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.71617056 |
| 91 | Salivary secretion_Homo sapiens_hsa04970 | 0.71599481 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.69780943 |
| 93 | Ribosome_Homo sapiens_hsa03010 | 0.69762291 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68964039 |
| 95 | Proteasome_Homo sapiens_hsa03050 | 0.67953345 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67300065 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.66721328 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66183687 |
| 99 | Axon guidance_Homo sapiens_hsa04360 | 0.66128954 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65732059 |
| 101 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65106469 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63599151 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.61684782 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61110869 |
| 105 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60368688 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58900865 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56919961 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56816752 |
| 109 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.56015353 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56006312 |
| 111 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54406975 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54168977 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53576590 |
| 114 | Long-term depression_Homo sapiens_hsa04730 | 0.53548640 |
| 115 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53336966 |
| 116 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.52511803 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51976324 |
| 118 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51493359 |
| 119 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51382443 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.50916043 |
| 121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50751706 |
| 122 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50118868 |
| 123 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50062856 |
| 124 | Phagosome_Homo sapiens_hsa04145 | 0.50018869 |
| 125 | Glioma_Homo sapiens_hsa05214 | 0.47802850 |
| 126 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45046164 |
| 127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44759622 |
| 128 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43938901 |
| 129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43731523 |
| 130 | Bile secretion_Homo sapiens_hsa04976 | 0.43278405 |
| 131 | Salmonella infection_Homo sapiens_hsa05132 | 0.42313027 |
| 132 | Focal adhesion_Homo sapiens_hsa04510 | 0.41010081 |
| 133 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40848599 |
| 134 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40581785 |
| 135 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39976350 |
| 136 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39822711 |
| 137 | Shigellosis_Homo sapiens_hsa05131 | 0.39401237 |
| 138 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38461271 |
| 139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37673297 |
| 140 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36074560 |
| 141 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.35875888 |
| 142 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.35820578 |
| 143 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35191207 |
| 144 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34356459 |
| 145 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34295217 |
| 146 | ABC transporters_Homo sapiens_hsa02010 | 0.34293969 |
| 147 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34186865 |
| 148 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.33626974 |
| 149 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.33406131 |
| 150 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.33212492 |
| 151 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.30211327 |
| 152 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29405124 |
| 153 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.28942492 |
| 154 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.28828410 |
| 155 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.28363412 |
| 156 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26899893 |
| 157 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.25946425 |
| 158 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.25676608 |

